潜在的药物诱导性便秘:使用日本索赔数据库的回顾性研究
Yusuke Karasawa1, Kazutaka Nozawa1, Atsushi Nakajima2
1Medical Affairs, Viatris Pharmaceuticals Japan Inc. Tokyo Japan.
JGH open : an open access journal of gastroenterology and hepatology
|February 16, 2024
概括
药物诱导性便秘 (DIC) 影响约11%的便秘患者. 心血管药物是常见的罪祸首. 识别DIC对于有效的患者治疗至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 胃肠病学 胃肠病学
- 现实世界的证据.
背景情况:
- 关于药物诱导便秘 (DIC) 的详细临床信息有限.
- 这项研究调查了DIC的现实世界流行率和特征.
研究的目的:
- 在现实世界中确定潜在的药物诱导便秘 (pDIC) 的比例.
- 确定pDIC的致病药物和相关因素.
主要方法:
- 日本索赔数据库 (2014-2021) 的回顾性分析.
- 便秘和非便秘队伍与已知致病药物 (CD) 的倾向性得分匹配.
- 后勤回归以确定pDIC的相关因素.
主要成果:
- 潜在的DIC (pDIC) 占治疗便秘病例的10.9%.
- 心血管药物是最常被处方的致病药物 (47.9%).
- 男性性别,特定的并发症,以及所有CD类与pDIC有关.
结论:
- 大约11%的便秘病例可能是药物诱导的.
- 医生必须了解DIC以优化治疗策略,将其与其他类型的便秘区分开来.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
164
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
164
Drugs for Treatment of Diarrhea-Predominant IBS
170
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
170
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
252
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
252
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Drugs Affecting GI Tract Motility: Other Laxatives
217
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
217
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
199
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
199


